2017-28176. Importer of Controlled Substances Application: ABBVIE LTD; Correction  

  • Start Preamble

    ACTION:

    Notice; correction.

    SUMMARY:

    The Drug Enforcement Administration (DEA) published a document in the Federal Register of December 1, 2017, concerning a notice of application that inadvertently misstated what the firm plans to do with imported tapentadol.

    Correction

    In the Federal Register of December 1, 2017, in FR Doc. 2017-25921 (82 FR 230), on page 230, in the second column, the last paragraph, correct the first sentence to read: The company plans to import bulk tapentadol (9780) to manufacture dosage form tapentadol (9780) for distribution to its customers.

    Start Signature

    Demetra Ashley,

    Acting Assistant Administrator.

    End Signature End Preamble

    [FR Doc. 2017-28176 Filed 12-28-17; 8:45 am]

    BILLING CODE 4410-09-P

Document Information

Published:
12/29/2017
Department:
Drug Enforcement Administration
Entry Type:
Notice
Action:
Notice; correction.
Document Number:
2017-28176
Pages:
61795-61795 (1 pages)
Docket Numbers:
Docket No. DEA-392
PDF File:
2017-28176.pdf